REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,019,137 | +660.5% | 29,611 | +650.4% | 0.00% | – |
Q3 2021 | $397,000 | -67.4% | 3,946 | -49.5% | 0.00% | -100.0% |
Q2 2020 | $1,219,000 | -73.3% | 7,810 | -75.3% | 0.00% | -80.0% |
Q1 2020 | $4,573,000 | -55.3% | 31,680 | -36.7% | 0.01% | -41.2% |
Q4 2019 | $10,225,000 | +118.7% | 50,016 | -14.1% | 0.02% | +88.9% |
Q3 2019 | $4,676,000 | -4.5% | 58,236 | +12.2% | 0.01% | 0.0% |
Q2 2019 | $4,898,000 | +125.0% | 51,917 | +103.8% | 0.01% | +125.0% |
Q1 2019 | $2,177,000 | -17.8% | 25,476 | -46.0% | 0.00% | -33.3% |
Q4 2018 | $2,648,000 | +906.8% | 47,198 | +1364.9% | 0.01% | – |
Q3 2018 | $263,000 | – | 3,222 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |